An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion gene

被引:28
|
作者
Toyokawa, Gouji [1 ]
Takenoyama, Mitsuhiro [1 ]
Taguchi, Kenichi [2 ]
Toyozawa, Ryo [1 ]
Inamasu, Eiko [1 ]
Kojo, Miyako [1 ]
Shiraishi, Yoshimasa [1 ]
Morodomi, Yosuke [1 ]
Takenaka, Tomoyoshi [1 ]
Hirai, Fumihiko [1 ]
Yamaguchi, Masafumi [1 ]
Seto, Takashi [1 ]
Shimokawa, Mototsugu [3 ]
Ichinose, Yukito [1 ]
机构
[1] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Minami Ku, Fukuoka 8111395, Japan
[2] Kyushu Natl Canc Ctr, Inst Clin Res, Canc Pathol Lab, Fukuoka 8111395, Japan
[3] Kyushu Natl Canc Ctr, Inst Clin Res, Fukuoka 8111395, Japan
关键词
Small-cell lung cancer; Oncogenic driver mutation; EML4-ALK; MUTATIONS;
D O I
10.1016/j.lungcan.2013.05.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Anaplastic lymphoma kinase (ALK) fuses echinoderm microtubule-associated protein-like 4 (EML4) to acquire a transforming activity in lung adenocarcinomas. However, the presence of an EML4-ALK fusion gene in other lung cancer histologies is an extremely rare phenomenon. A 43-year-old female was referred to our department due to dyspnea on effort and left back pain. Computed tomography (CT) showed a large mass in the upper lobe of the left lung and a massive left pleural effusion, while a CT-guided needle biopsy confirmed a diagnosis of small-cell lung cancer (SCLC). Surprisingly, the tumor was genetically considered to harbor the EML4-ALK fusion gene (variant 2). Although the patient underwent two regimens of cytotoxic chemotherapy for SCLC, she died approximately seven months after the administration of first-line chemotherapy. Our analysis of 30 consecutive patients with SCLC for EML4-ALK revealed that two patients, including the current patient and a patient we previously reported, harbored the EML4-ALK fusion gene. (c) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:487 / 490
页数:4
相关论文
共 50 条
  • [21] EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
    Koivunen, Jussi P.
    Mermel, Craig
    Zejnullahu, Kreshnik
    Murphy, Carly
    Lifshits, Eugene
    Holmes, Alison J.
    Choi, Hwan Geun
    Kim, Jhingook
    Chiang, Derek
    Thomas, Roman
    Lee, Jinseon
    Richards, William G.
    Sugarbaker, David J.
    Ducko, Christopher
    Lindeman, Neal
    Marcoux, J. Paul
    Engelman, Jeffrey A.
    Gray, Nathanael S.
    Lee, Charles
    Meyerson, Matthew
    Janne, Pasi A.
    CLINICAL CANCER RESEARCH, 2008, 14 (13) : 4275 - 4283
  • [22] CONCOMITANT EGFR MUTATION AND EML4-ALK GENE FUSION IN NON-SMALL CELL LUNG CANCER
    Yang, Jinji
    Zhang, Xuchao
    Su, Jian
    Chen, Hua-Jun
    Tian, Hong-Xia
    Huang, Yi-Sheng
    Xu, Chong-Rui
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1518 - S1518
  • [23] A CASE OF LUNG ADENOCARCINOMA HARBORING BOTH A KRAS MUTATION AND AN EML4-ALK FUSION GENE WITH RESPONSE TO CRIZOTINIB
    Menefee, Michael E.
    D'Amico, Thomas A.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1315 - S1316
  • [24] CLINICAL AND BIOLOGICAL FEATURES ASSOCIATED WITH EML4-ALK FUSION GENE IN NON SMALL CELL LUNG CANCER
    Choi, C.
    Jang, S. H.
    Hwang, Y. I.
    Jung, J. H.
    Lee, Y. Y.
    Lee, J. C.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S44 - S44
  • [25] The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
    Bilgin, Burak
    Sendur, Mehmet Ali Nahit
    Yucel, Sebnem
    Hizal, Mutlu
    Guner, Gurkan
    Akyurek, Nalan
    Erol, Cihan
    Akinci, Muhammed Bulent
    Dede, Didem Sener
    Yalcin, Bulent
    Kilickap, Sadettin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2637 - 2643
  • [26] The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
    Burak Bilgin
    Mehmet Ali Nahit Şendur
    Şebnem Yücel
    Mutlu Hizal
    Gürkan Güner
    Nalan Akyürek
    Cihan Erol
    Muhammed Bülent Akıncı
    Didem Şener Dede
    Bülent Yalçın
    Sadettin Kılıçkap
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2637 - 2643
  • [27] Primary lung adenocarcinoma with breast metastasis harboring the EML4-ALK fusion: A case report
    Zhang, Wenwen
    Zhang, Yu
    Zhou, Lei
    Tan, Na
    Bai, Yuju
    Xing, Shiyun
    ONCOLOGY LETTERS, 2024, 27 (06)
  • [28] Endobronchial Metastases in Lung Cancer Harboring EML4-ALK Rearrangement
    Ijichi, Miharu
    Fukuda, Yosuke
    Kashima, Ayaka
    Sagara, Hironori
    INTERNAL MEDICINE, 2023, 62 (13) : 2021 - 2022
  • [29] A RARE CASE OF PEDIATRIC SPINDLE CELL ONCOCYTOMA WITH EML4-ALK FUSION
    Michaiel, George
    Hawes, Debra
    Guzman, Samuel
    Margol, Ashley
    Biegel, Jaclyn
    Ji, Jianling
    NEURO-ONCOLOGY, 2021, 23 : 45 - 45
  • [30] EML4-ALK FUSION GENE IN LUNG ADENOCARCINOMA IN THAILAND
    Prempree, Thongbliew
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1023 - S1024